drugset
drugset / Trial / NCT04883658

A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-348(2)

NCT04883658 ↗

Phase 1 Completed 62 enrolled Chong Kun Dang Pharmaceutical
RandomizedParallel-groupOpen-labelTreatment

Summary

A Clinical Trial to evaluate the Pharmacokinetics and Tolerability of CKD-348(2)

Timeline

Start
2021-06-04
Primary completion
2021-07-20
Completion
2021-08-19

Drugs

EvaluationDrugModalityDoseRoute
Subject CKD-348(2) Unknown — Oral
Subject CKD-828 Unknown — Oral
Subject D097 Unknown — Oral
Subject D337 Unknown — Oral

Indications

No indication recorded.